Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

There’s been a “stark increase” in the share of large businesses covering GLP-1s for weight loss, new research shows.

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...

For people with abnormally high blood sugar levels, losing weight is often proposed as the primary approach to preventing ...

In a state where the obesity rate ranks among the highest in the country, many health providers were thrilled when ...

Weight loss drugs are proving to be super popular among many workers with job-based health insurance.But GLP-1 medications are busting their employers’ budgets, leading some firms to rethink their ...

The partnership with Noom aims to cut costs by treating weight management as preventative healthcare. Nearly 2 million ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

Highmark will start covering Noom — a subscription-based app that claims to enable weight loss by harnessing psychological ...

Weight loss can feel deeply personal, like something you should be able to manage on your own. With so many diet plans, ...

Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...